Back at a start-up. A few years ago, I co-founded Amygdala Neurosciences, Inc. We acquired an asset from Gilead Sciences which we are now developing to treat substance use disorders. We are starting Phase 2 studies for smoking cessation and opioid, alcohol, and cocaine use disorders.
Suzanne and I still live in San Francisco and, with our youngest off to college in the fall, are looking forward to being empty nesters.
Contact Peter at: